Vaccination with Plasmids Encoding the GP63 Glycoprotein and CD40L Results in a Partial Suppression of the Inflammatory Reaction after Experimental Infection
The development of an effective vaccine against leishmaniasis is the aim of an intensive research effort, to bring relief to thousands of people worldwide. DNA vaccination is a promising approach in this direction, since it is able to generate a strong cellular immune response. We tested whether the...
Main Authors: | P. Tsagozis, V. Tseveleki, L. Probert, E. Dotsika, E. Karagouni |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2004-05-01
|
Series: | European Journal of Inflammation |
Online Access: | https://doi.org/10.1177/1721727X0400200207 |
Similar Items
-
Low CD40 Expression Levels in Infantum-Infected Bone Marrow Dendritic Cells Evoke Regulatory Responses by Down-Regulating Interleukin-12 Production: Role of ERK1/2
by: M. Agallou, et al.
Published: (2014-05-01) -
Stable expression of mucin glycoproteins GP40 and GP15 of Cryptosporidium parvum in Toxoplasma gondii
by: Muxiao Li, et al.
Published: (2024-02-01) -
Structure and transcription of genes encoding the surface glycoprotein antigens gp90 and gp82 of Trypanosoma cruzi metacyclic trypomastigotes
by: Carmo Mirian S., et al.
Published: (2000-01-01) -
The immunogenicity and protective immunity of multi-epitopes DNA prime-protein boost vaccines encoding Amastin-Kmp-11, Kmp11-Gp63 and Amastin-Gp63 against visceral leishmaniasis.
by: Jianhui Zhang, et al.
Published: (2020-01-01) -
Impact of Leishmania Metalloprotease GP63 on Macrophage Signalling
by: Amandine eIsnard, et al.
Published: (2012-05-01)